High Risk of Cardiovascular Disease in Patients With Type 1 Diabetes in the U.K.
Sabita S. Soedamah‐Muthu(The Royal Free Hospital), Helen M. Colhoun(Western General Hospital), Henrietta Mulnier(University of Surrey), Ross Lawrenson(University of Auckland), Veena Raleigh(University of Surrey), John Fuller(The Royal Free Hospital)
Cited by 393
Related Papers
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
|The Lancet|2004|3.8k
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
|New England Journal of Medicine|2023|2.6k
Vascular Risk Factors and Diabetic Neuropathy
|New England Journal of Medicine|2005|1.3k